微生物与子痫前期的研究进展

doi:10.12280/gjfckx.20200900

摘要/Abstract

摘要：

子痫前期（PE）是一种多系统受累的妊娠并发症,与全球母亲和胎儿的死亡率和发病率有关。胎盘中螺旋动脉的异常重塑、胎盘缺陷、母胎界面的氧化应激、母体循环中的炎症和血管生成障碍是PE的主要原因。这些事件导致全身弥漫性内皮细胞功能障碍,这是PE的基本病理生理特征。微生物及其衍生物通过产生抗原和其他炎性因子可能触发感染和炎性反应。母亲在口腔、肠道、阴道、宫颈和子宫中的细菌群落以及胎盘和羊水微生物群可能与PE的发展有关。综述细菌及其衍生物在PE发展中的机制和致病作用,强调了一组母体微生物群的改变（菌群失调）对PE发病机制的影响。

关键词: 先兆子痫, 微生物群, 胃肠道微生物组, 幽门螺杆菌, 炎症

Abstract:

Pre-eclampsia (PE) is a multisystem pregnancy complication associated with maternal and fetal mortality and morbidity worldwide. Abnormal remodeling of spiral arteries in placenta, placental defects, oxidative stress at maternal-fetal interface, inflammation in maternal circulation and disturbance of angiogenesis are the main causes of PE. These events lead to systemic diffuse endothelial cell dysfunction, which is the basic pathophysiological feature of PE. Microorganisms and their derivatives may trigger infection and inflammatory responses by producing antigens and other inflammatory factors. The bacterial community in the mouth, intestines, vagina, cervix and uterus of the mother, as well as the microflora of placenta and amniotic fluid may be related to the development of PE. We reviewed the mechanism and pathogenicity of bacteria and their derivatives in the development of PE and emphasized the effect of a group of maternal microbiota changes (flora imbalance) on the pathogenesis of PE.

Key words: Pre-eclampsia, Microbiota, Gastrointestinal microbiome, Helicobacter pylori, Inflammation

张体硕, 王玲, 王一男, 周顺卿, 段雪峰, 韩丽英. 微生物与子痫前期的研究进展[J]. 国际妇产科学杂志, 2021, 48(2): 173-177.

ZHANG Ti-shuo, WANG Ling, WANG Yi-nan, ZHOU Shun-qing, DUAN Xue-feng, HAN Li-ying. Research Progress of Microorganisms and Pre-Eclampsia[J]. Journal of International Obstetrics and Gynecology, 2021, 48(2): 173-177.

参考文献 40

[1]	Brown MA, Magee LA, Kenny LC, et al. Hypertensive Disorders of Pregnancy: ISSHP Classification, Diagnosis, and Management Recommendations for International Practice[J]. Hypertension, 2018,72(1):24-43. doi: 10.1016/j.preghy.2018.05.004. doi: 10.1161/HYPERTENSIONAHA.117.10803 pmid: 29899139
[2]	Mol BWJ, Roberts CT, Thangaratinam S, et al. Pre-eclampsia[J]. Lancet, 2016,387(10022):999-1011. doi: 10.1016/S0140-6736(15)00070-7. doi: 10.1016/S0140-6736(15)00070-7 pmid: 26342729
[3]	Chiarello DI, Abad C, Rojas D, et al. Oxidative stress: Normal pregnancy versus preeclampsia[J]. Biochim Biophys Acta Mol Basis Dis, 2020,1866(2):165354. doi: 10.1016/j.bbadis.2018.12.005. pmid: 30590104
[4]	Ahmadian E, Rahbar Saadat Y, Hosseiniyan Khatibi SM, et al. Pre-Eclampsia: Microbiota possibly playing a role[J]. Pharmacol Res, 2020,155:104692. doi: 10.1016/j.phrs.2020.104692. doi: 10.1016/j.phrs.2020.104692 pmid: 32070720
[5]	Perez-Muñoz ME, Arrieta MC, Ramer-Tait AE, et al. A critical assessment of the "sterile womb" and "in utero colonization" hypotheses: implications for research on the pioneer infant microbiome[J]. Microbiome, 2017,5(1):48. doi: 10.1186/s40168-017-0268-4. doi: 10.1186/s40168-017-0268-4 pmid: 28454555
[6]	Beckers KF, Sones JL. Maternal microbiome and the hypertensive disorder of pregnancy, preeclampsia[J]. Am J Physiol Heart Circ Physiol, 2020,318(1):H1-H10. doi: 10.1152/ajpheart.00469.2019. pmid: 31626558
[7]	Jama HA, Kaye DM, Marques FZ. The gut microbiota and blood pressure in experimental models[J]. Curr Opin Nephrol Hypertens, 2019,28(2):97-104. doi: 10.1097/MNH.0000000000000476. doi: 10.1097/MNH.0000000000000476 pmid: 30531472
[8]	Fujisaka S, Avila-Pacheco J, Soto M, et al. Diet,Genetics,and the Gut Microbiome Drive Dynamic Changes in Plasma Metabolites[J]. Cell Rep, 2018,22(11):3072-3086. doi: 10.1016/j.celrep.2018.02.060. pmid: 29539432
[9]	Aydin S, Ustebay S, Baykus Y, et al. May probable cause of hypertension in hypertensive disorders of pregnancy be over expressing tyramine depending deterioration of microbiota composition[J]. Med Hypotheses, 2019,122:139-140. doi: 10.1016/j.mehy.2018.11.011. doi: 10.1016/j.mehy.2018.11.011 pmid: 30593398
[10]	Taddei CR, Cortez RV, Mattar R, et al. Microbiome in normal and pathological pregnancies: A literature overview[J]. Am J Reprod Immunol, 2018,80(2):e12993. doi: 10.1111/aji.12993. doi: 10.1111/aji.12993 pmid: 29873429
[11]	Gomez-Arango LF, Barrett HL, McIntyre HD, et al. Increased Systolic and Diastolic Blood Pressure Is Associated With Altered Gut Microbiota Composition and Butyrate Production in Early Pregnancy[J]. Hypertension, 2016,68(4):974-981. doi: 10.1161/HYPERTENSIONAHA.116.07910. doi: 10.1161/HYPERTENSIONAHA.116.07910 pmid: 27528065
[12]	Bardos J, Fiorentino D, Longman RE, et al. Immunological Role of the Maternal Uterine Microbiome in Pregnancy: Pregnancies Pathologies and Alterated Microbiota[J]. Front Immunol, 2019,10:2823. doi: 10.3389/fimmu.2019.02823. pmid: 31969875
[13]	Cunningham MW Jr, Castillo J, Ibrahim T, et al. AT1-AA (Angiotensin II Type 1 Receptor Agonistic Autoantibody) Blockade Prevents Preeclamptic Symptoms in Placental Ischemic Rats[J]. Hypertension, 2018,71(5):886-893. doi: 10.1161/HYPERTENSIONAHA.117.10681. doi: 10.1161/HYPERTENSIONAHA.117.10681 pmid: 29555668
[14]	Phipps EA, Thadhani R, Benzing T, et al. Author Correction: Pre-eclampsia: pathogenesis, novel diagnostics and therapies[J]. Nat Rev Nephrol, 2019,15(6):386. doi: 10.1038/s41581-019-0156-1. doi: 10.1038/s41581-019-0156-1 pmid: 31068691
[15]	Hawkesworth S, Moore SE, Fulford AJ, et al. Evidence for metabolic endotoxemia in obese and diabetic Gambian women[J]. Nutr Diabetes, 2013,3:e83. doi: 10.1038/nutd.2013.24. doi: 10.1038/nutd.2013.24 pmid: 23978817
[16]	Cobb CM, Kelly PJ, Williams KB, et al. The oral microbiome and adverse pregnancy outcomes[J]. Int J Womens Health, 2017,9:551-559. doi: 10.2147/IJWH.S142730. pmid: 28848365
[17]	Nakajima T, Honda T, Domon H, et al. Periodontitis-associated up-regulation of systemic inflammatory mediator level may increase the risk of coronary heart disease[J]. J Periodontal Res, 2010,45(1):116-122. doi: 10.1111/j.1600-0765.2009.01209.x. doi: 10.1111/j.1600-0765.2009.01209.x pmid: 19602107
[18]	Jaiman G, Nayak PA, Sharma S, et al. Maternal periodontal disease and preeclampsia in Jaipur population[J]. J Indian Soc Periodontol, 2018,22(1):50-54. doi: 10.4103/jisp.jisp_363_15. pmid: 29568173
[19]	Sumathy V, Suryakirnmayi R, Padmanaban S, et al. Study on association of maternal periodontitis and preeclampsia[J]. J Obstet Gynaecol, 2018,2(5):32-35. https://www.researchgate.net/publication/328225933. doi: 10.3109/01443618109067406
[20]	Conde-Agudelo A, Villar J, Lindheimer M. Maternal infection and risk of preeclampsia: systematic review and metaanalysis[J]. Am J Obstet Gynecol, 2008,198(1):7-22. doi: 10.1016/j.ajog.2007.07.040. doi: 10.1016/j.ajog.2007.07.040 pmid: 18166297
[21]	Parthiban PS, Mahendra J, Logaranjani A, et al. Association between specific periodontal pathogens, Toll-like receptor-4, and nuclear factor-κB expression in placental tissues of pre-eclamptic women with periodontitis[J]. J Investig Clin Dent, 2018,9:e12265. doi: 10.1111/jicd.12265.
[22]	Koren O, Goodrich JK, Cullender TC, et al. Host remodeling of the gut microbiome and metabolic changes during pregnancy[J]. Cell, 2012,150(3):470-480. doi: 10.1016/j.cell.2012.07.008. doi: 10.1016/j.cell.2012.07.008 pmid: 22863002
[23]	Chen X, Li P, Liu M, et al. Gut dysbiosis induces the development of pre-eclampsia through bacterial translocation[J]. Gut, 2020,69(3):513-522. doi: 10.1136/gutjnl-2019-319101. doi: 10.1136/gutjnl-2019-319101 pmid: 31900289
[24]	Liu J, Yang H, Yin Z, et al. Remodeling of the gut microbiota and structural shifts in Preeclampsia patients in South China[J]. Eur J Clin Microbiol Infect Dis, 2017,36(4):713-719. doi: 10.1007/s10096-016-2853-z. doi: 10.1007/s10096-016-2853-z pmid: 27988814
[25]	Lv LJ, Li SH, Li SC, et al. Early-Onset Preeclampsia Is Associated With Gut Microbial Alterations in Antepartum and Postpartum Women[J]. Front Cell Infect Microbiol, 2019,9:224. doi: 10.3389/fcimb.2019.00224. doi: 10.3389/fcimb.2019.00224 pmid: 31297341
[26]	Schiering C, Wincent E, Metidji A, et al. Feedback control of AHR signalling regulates intestinal immunity[J]. Nature, 2017,542(7640):242-245. doi: 10.1038/nature21080. doi: 10.1038/nature21080 pmid: 28146477
[27]	de Brito Alves JL, de Oliveira Y, Carvalho N, et al. Gut microbiota and probiotic intervention as a promising therapeutic for pregnant women with cardiometabolic disorders: Present and future directions[J]. Pharmacol Res, 2019,145:104252. doi: 10.1016/j.phrs.2019.104252. doi: 10.1016/j.phrs.2019.104252 pmid: 31054952
[28]	Stout MJ, Zhou Y, Wylie KM, et al. Early pregnancy vaginal microbiome trends and preterm birth[J]. Am J Obstet Gynecol, 2017,217(3):356.e1-e18. doi: 10.1016/j.ajog.2017.05.030. doi: 10.1016/j.ajog.2017.05.030
[29]	Ivankiv VY, Malanchyn IM, Tkachuk NI. Microbiota of vagina and mammary glands skin in the pregnant women with preeclampsia[J]. Int J Med Med Resea, 2018 , 4(2):44-49. doi: 10.11603/ijmmr.2413-6077.2018.2.9347.
[30]	Moreno I, Codoñer FM, Vilella F, et al. Evidence that the endometrial microbiota has an effect on implantation success or failure[J]. Am J Obstet Gynecol, 2016,215(6):684-703. doi: 10.1016/j.ajog.2016.09.075. doi: 10.1016/j.ajog.2016.09.075 pmid: 27717732
[31]	Garcia-Grau I, Simon C, Moreno I. Uterine microbiome-low biomass and high expectations?[J]. Biol Reprod, 2019,101(6):1102-1114. doi: 10.1093/biolre/ioy257. doi: 10.1093/biolre/ioy257 pmid: 30544156
[32]	Moreno I, Simon C. Deciphering the effect of reproductive tract microbiota on human reproduction[J]. Reprod Med Biol, 2019,18(1):40-50. doi: 10.1002/rmb2.12249. pmid: 30655720
[33]	Aagaard K, Ma J, Antony KM, et al. The placenta harbors a unique microbiome[J]. Sci Transl Med, 2014,6(237):237ra65. doi: 10.1126/scitranslmed.3008599. doi: 10.1126/scitranslmed.3009154 pmid: 24848253
[34]	Amarasekara R, Jayasekara RW, Senanayake H, et al. Microbiome of the placenta in pre-eclampsia supports the role of bacteria in the multifactorial cause of pre-eclampsia[J]. J Obstet Gynaecol Res, 2015,41(5):662-669. doi: 10.1111/jog.12619. doi: 10.1111/jog.12619 pmid: 25492799
[35]	Nizyaeva N, Lyubasovskaya L, Gordeev A, et al. The disturbance of opportunistic placenta microflora as a trigger for preeclampsia pathogenesis[J]. Virchows Arch, 2017,471(1):S97. doi: 10.13140/RG.2.2.11683.55845.
[36]	DiGiulio DB, Gervasi M, Romero R, et al. Microbial invasion of the amniotic cavity in preeclampsia as assessed by cultivation and sequence-based methods[J]. J Perinat Med, 2010,38(5):503-513. doi: 10.1515/jpm.2010.078. pmid: 20482470
[37]	Dunn AB, Hanson L, VandeVusse L, et al. Through the Microbial Looking Glass: Premature Labor, Preeclampsia, and Gestational Diabetes: A Scoping Review[J]. J Perinat Neonatal Nurs, 2019,33(1):35-51. doi: 10.1097/JPN.0000000000000375. pmid: 30676461
[38]	Di Simone N, Tersigni C, Cardaropoli S, et al. Helicobacter pylori infection contributes to placental impairment in preeclampsia: basic and clinical evidences[J]. Helicobacter, 2017,22:e12347. doi: 10.1111/hel.12347. doi: 10.1111/hel.2017.22.issue-2
[39]	Nourollahpour Shiadeh M, Riahi SM, Adam I, et al. Helicobacter pylori infection and risk of preeclampsia: a systematic review and meta-analysis[J]. J Matern Fetal Neonatal Med, 2019,32(2):324-331. doi: 10.1080/14767058.2017.1378331. doi: 10.1080/14767058.2017.1378331 pmid: 28889771
[40]	Brantsaeter AL, Myhre R, Haugen M, et al. Intake of probiotic food and risk of preeclampsia in primiparous women: the Norwegian Mother and Child Cohort Study[J]. Am J Epidemiol, 2011,174(7):807-815. doi: 10.1093/aje/kwr168. doi: 10.1093/aje/kwr168 pmid: 21821542